A Phase 1b Open-label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma.Mehr…
A phase 2, single-arm, multicohort, multicentral trial to determine the efficiancy and safety of JCAR017 in adult subjects with aggressive B-Cell non-hodgkin lymphoma.Mehr…
